Related Experiment Videos
Changing trends in sympathetic ophthalmia
Clinical & Experimental Ophthalmology
|October 23, 2004
Summary
Sympathetic ophthalmia, a severe eye inflammation, can occur after vitreoretinal surgery. Early immunosuppressive treatment is crucial for preserving vision in the unaffected eye.
Area of Science:
- Ophthalmology
- Immunology
Background:
- Sympathetic ophthalmia is a rare, severe bilateral panuveitis.
- It typically follows penetrating ocular trauma but can also occur post-surgery.
Observation:
- Three cases of sympathetic ophthalmia developing after repeated vitreoretinal surgery are presented.
- This highlights vitreoretinal surgery as a significant risk factor.
Findings:
- Prompt management with systemic immunosuppressive agents controlled the disease.
- Patients retained good visual acuity in their remaining eye.
Implications:
- Informed consent for vitreoretinal surgery must include the risk of sympathetic ophthalmia (approx. 1 in 800).
- Diverse presentations necessitate vigilance for bilateral uveitis post-surgery.
- Modern immunosuppressive therapy improves prognosis with early diagnosis and treatment.